Author Correction: Current and future colorectal cancer screening strategies.
作者信息
Shaukat Aasma, Levin Theodore R
机构信息
Division of Gastroenterology, Department of Medicine, NYU Grossman School of Medicine, New York City, NY, USA.
New York Harbour Veterans Affairs Healthcare System New York City, New York City, NY, USA.
出版信息
Nat Rev Gastroenterol Hepatol. 2022 Aug;19(8):551. doi: 10.1038/s41575-022-00661-3.
Abstract
摘要
相似文献
1
Author Correction: Current and future colorectal cancer screening strategies.作者更正：当前及未来的结直肠癌筛查策略。
Nat Rev Gastroenterol Hepatol. 2022 Aug;19(8):551. doi: 10.1038/s41575-022-00661-3.
2
Author Correction: Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer.作者更正：种系易感性变异影响III期结直肠癌的临床结局和治疗策略。
Sci Rep. 2020 Jul 17;10(1):12216. doi: 10.1038/s41598-020-69145-1.
3
Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies.基于血液生物标志物的结直肠癌筛查：甲基化 Septin 9 DNA 与现行策略的成本效益比较。
Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1567-76. doi: 10.1158/1055-9965.EPI-13-0204. Epub 2013 Jun 24.
4
Colorectal cancer: update on recent advances and their impact on screening protocols.结直肠癌：近期进展及其对筛查方案影响的最新情况
J Natl Med Assoc. 2000 May;92(5):222-30.
5
[Mass screening for colorectal cancer--issues and future prospects].
Gan No Rinsho. 1984 May;30(6 Suppl):611-5.
6
[Priority setting in scaled-up cancer screening in China: an systematic review of economic evaluation evidences].[中国扩大癌症筛查中的优先事项设定：经济评估证据的系统评价]
Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Mar 6;54(3):306-313. doi: 10.3760/cma.j.issn.0253-9624.2020.03.012.
7
Author Correction: The Expression Analysis of Intestinal Cancer Stem Cell Marker Lgr5 in Colorectal Cancer Patients and the Correlation with Histopathological Markers.作者更正：结直肠癌患者中肠道癌干细胞标志物Lgr5的表达分析及其与组织病理学标志物的相关性
J Gastrointest Cancer. 2020 Jun;51(2):600. doi: 10.1007/s12029-019-00305-x.
9
Association between age factors and strategies for promoting participation in gastric and colorectal cancer screenings.年龄因素与促进胃和结直肠癌筛查参与策略之间的关联。
BMC Cancer. 2018 Mar 27;18(1):345. doi: 10.1186/s12885-018-4244-6.
10
Colorectal cancer screening: present strategies and future prospects.结直肠癌筛查：当前策略与未来前景。
Postgrad Med. 1996 Mar;99(3):253-64.
引用本文的文献
1
Assessment of Fecal Occult Blood Testing in Acute Hospital Settings: Perspectives of Internal Medicine Residents in a Multicenter Study.急性医院环境中粪便潜血检测的评估：多中心研究中内科住院医师的观点
Cureus. 2025 Jul 22;17(7):e88524. doi: 10.7759/cureus.88524. eCollection 2025 Jul.
2
Advances in colorectal cancer screening and detection: a narrative review on biomarkers, imaging and preventive strategies.结直肠癌筛查与检测的进展：关于生物标志物、影像学及预防策略的叙述性综述
J Egypt Natl Canc Inst. 2025 Apr 11;37(1):20. doi: 10.1186/s43046-025-00277-z.
3
Epidemiology of Rectal Cancer Patients in the Kingdom of Bahrain: A Retrospective Cohort Study.巴林王国直肠癌患者的流行病学：一项回顾性队列研究。
Euroasian J Hepatogastroenterol. 2024 Jul-Dec;14(2):205-209. doi: 10.5005/jp-journals-10018-1454. Epub 2024 Dec 27.
4
Ferroptosis: the balance between death and survival in colorectal cancer.铁死亡：结直肠癌中死亡与生存之间的平衡
Int J Biol Sci. 2024 Jul 2;20(10):3773-3783. doi: 10.7150/ijbs.96828. eCollection 2024.
Zotero 插件